The brand name for diazoxide is Proglycem [1].
What is Proglycem used for?
Proglycem is a prescription medication used to manage hypoglycemia, or low blood sugar, in infants and children. It is particularly indicated for conditions like islet cell hyperplasia, \textit{insulindependent} diabetes, leucine sensitivity, or other rare causes of hyperinsulinism [1].
How does diazoxide work?
Diazoxide is a potassium channel opener. By opening ATP-sensitive potassium channels on the plasma membrane of pancreatic beta cells, it leads to hyperpolarization of these cells. This hyperpolarization inhibits the release of insulin, thereby increasing blood glucose levels [2].
What are the potential side effects of diazoxide?
Common side effects associated with diazoxide include gastrointestinal issues such as nausea, vomiting, and diarrhea. It can also cause fluid retention, leading to edema, and potentially hair growth (hypertrichosis) [1]. Other possible side effects include increased heart rate, and effects on blood sugar levels (both increasing and sometimes decreasing) [2].
When does diazoxide's patent protection end?
Information regarding the specific patent expiration dates for diazoxide can be found through resources that track drug patents and exclusivity periods. DrugPatentWatch.com provides such data, which is crucial for understanding when generic versions might become available [3].
Can generic versions of diazoxide be used?
Once patent protections and any associated market exclusivities expire, generic versions of diazoxide may become available. Generic medications offer a lower-cost alternative to the brand-name drug, provided they are approved by regulatory agencies and meet the same standards for safety, efficacy, and quality [3].
What is the difference between diazoxide and other hypoglycemia treatments?
Diazoxide's mechanism of action, opening potassium channels to reduce insulin secretion, distinguishes it from other treatments. For example, some approaches might involve dietary management or medications that directly increase insulin sensitivity or reduce glucose production. The choice of treatment depends on the underlying cause and severity of the hypoglycemia [2].
How is diazoxide administered?
Proglycem is available as an oral suspension [1]. The dosage and frequency of administration are determined by a healthcare provider based on the patient's individual needs and response to the medication [2].
Where can I find more information on diazoxide patents?
DrugPatentWatch.com is a comprehensive resource for information on drug patents, patent litigation, and exclusivity timelines. It can provide detailed insights into the patent status of medications like diazoxide [3].
Sources
1. https://www.drugs.com/proglycem.html
2. https://www.ncbi.nlm.nih.gov/books/NBK534840/
3. https://drugpatentwatch.com/